Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chimeric opioid peptides: tools for identifying opioid receptor types.

G X Xie1, A Miyajima, T Yokota

  • 1Department of Molecular Biology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304.

Proceedings of the National Academy of Sciences of the United States of America
|April 1, 1990
PubMed
Summary

Researchers created new chimeric peptides by swapping parts of opioid receptor-selective molecules. These novel peptides maintain receptor selectivity and can be used to isolate and identify opioid receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of self-management program associated with a spa therapy for knee osteoarthritis patients (GETT 2): a research protocol for a randomized trial.

Trials·2023
Same author

A bright γ-ray flare interpreted as a giant magnetar flare in NGC 253.

Nature·2021
Same author

Involvement of the Spinal Cord in Primary Mitochondrial Disorders: A Neuroimaging Mimicker of Inflammation and Ischemia in Children.

AJNR. American journal of neuroradiology·2021
Same author

Use of Co<sup>2+</sup>:MgAl<sub>2</sub>O<sub>4</sub> transparent ceramics in passive Q-switching of an Er:Glass laser at 1.534 µm.

Optics express·2020
Same author

The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders.

AJNR. American journal of neuroradiology·2020
Same author

Prediction-based neural mechanisms for shielding the self from existential threat.

NeuroImage·2019

Area of Science:

  • Biochemistry
  • Molecular Pharmacology
  • Neuroscience

Background:

  • Opioid receptors (mu, delta, kappa) are critical targets for pain management and neurological research.
  • Dynorphin-32 is a known kappa opioid receptor-selective peptide.
  • Developing tools to specifically isolate and identify different opioid receptor subtypes is essential for advancing research.

Purpose of the Study:

  • To synthesize and characterize novel chimeric peptides with modified receptor selectivity.
  • To investigate the utility of these chimeric peptides in isolating and identifying opioid receptors.
  • To explore the broader applicability of this chimeric peptide approach for other peptide receptors.

Main Methods:

  • Synthesis of chimeric peptides by replacing the N-terminal residues of dynorphin-32 with sequences from other opioid receptor-selective peptides.

Related Experiment Videos

  • Assessment of the binding affinity and receptor type selectivity of the synthesized chimeric peptides.
  • Evaluation of the chimeric peptides' ability to bind a common monoclonal antibody when associated with cell surface or membrane-bound receptors.

    • Main Results:

    • Chimeric peptides successfully retained the high affinity and receptor type selectivity of their N-terminal sequences.
    • A common C-terminal region of the chimeric peptides served as a specific epitope for a monoclonal antibody.
    • The monoclonal antibody could bind to the chimeric peptides even when they were bound to opioid receptors on cells or membranes.

    Conclusions:

    • The synthesized chimeric peptides are valuable tools for the isolation of mu, delta, and kappa opioid receptors.
    • These peptides facilitate the identification of opioid receptors on transfected cells during expression cloning.
    • The chimeric peptide strategy offers a versatile approach applicable to the study of other peptide receptors.